Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports worldwide in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
148 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Aug 27 · Earnings today · 4 companies | |||||
| PRTC.L | PureTech Health plc | Oncology | $398.28M | +0.17% | |
| BINV.ST | BioInvent International AB (publ) | Oncology | $162.35M | +5.42% | |
| 0RU5.L | Oncoinvent ASA | Oncology | $128.23M | 0.00% | |
| 0VQ.DE | PureTech Health plc | Oncology | — | 0.00% | |
| Monday, Aug 31 · in 4 days · 1 company | |||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| BLRX | BioLineRx Ltd. | Oncology | $11.79M | −3.91% |
| Wednesday, Sep 2 · in 6 days · 1 company | |||||
| IMMP | Immutep Limited | Oncology | $56.00M | −2.56% | |
| Wednesday, Sep 9 · in 13 days · 1 company | |||||
| ANIX | Anixa Biosciences, Inc. | Oncology | $122.65M | +2.41% | |
| Thursday, Sep 17 · in 21 days · 3 companies | |||||
| IPHA | Innate Pharma S.A. | Oncology | $253.56M | +28.57% | |
| IDD.DE | Innate Pharma S.A. | Oncology | $243.27M | +12.80% | |
| IPH.PA | Innate Pharma S.A. | Oncology | $240.15M | +19.01% | |
| Monday, Sep 28 · in 32 days · 3 companies | |||||
| OSE.PA | OSE Immunotherapeutics SA | Oncology | $88.75M | −0.19% | |
| 0RAD.L | OSE Immunotherapeutics SA | Oncology | $51.87M | −1.30% | |
| LNAI | Lunai Bioworks Inc. | Oncology | $9.97M | −1.79% | |
| Tuesday, Sep 29 · in 33 days · 3 companies | |||||
| NBTX | Nanobiotix S.A. | Oncology | $2.26B | +17.66% | |
| NANO.PA | Nanobiotix S.A. | Oncology | $2.05B | +8.43% | |
| 0QAV.L | Nanobiotix S.A. | Oncology | $671.98M | −1.38% | |
| Thursday, Oct 8 · in 42 days · 1 company | |||||
| NRIX | Nurix Therapeutics, Inc. | Oncology | $2.77B | +10.60% | |
| Monday, Oct 19 · in 53 days · 1 company | |||||
| SMMT | Summit Therapeutics Inc. | Oncology | $11.35B | +13.39% | |
| Tuesday, Oct 27 · in 61 days · 6 companies | |||||
| 4519.T | Chugai Pharmaceutical Co., Ltd. | Oncology | $71.92B | −1.64% | |
| INCY | Incyte Corporation | Oncology | $25.97B | −1.39% | |
| 0J9P.L | Incyte Corporation | Oncology | $21.10B | +1.10% | |
| EXEL | Exelixis, Inc. | Oncology | $14.05B | −0.73% | |
| 0IJO.L | Exelixis, Inc. | Oncology | $14.05B | +4.53% | |
| RCUS | Arcus Biosciences, Inc. | Oncology | $3.92B | +13.72% | |
| Wednesday, Oct 28 · in 62 days · 2 companies | |||||
| 0KCS.L | OPKO Health, Inc. | Oncology | $578.38M | +0.68% | |
| 0IMT.L | Photocure ASA | Oncology | $144.18M | +0.35% | |
| Thursday, Oct 29 · in 63 days · 8 companies | |||||
| 6MK.DE | Merck & Co., Inc. | Oncology | $379.64B | +14.19% | |
| MRK | Merck & Co., Inc. | Oncology | $377.72B | +16.14% | |
| BMY | Bristol-Myers Squibb Company | Oncology | $138.03B | +6.24% | |
| 4528.T | Ono Pharmaceutical Co., Ltd. | Oncology | $7.39B | −1.16% | |
| NVCR | NovoCure Limited | Oncology | $2.08B | +9.69% | |
| BCYC | Bicycle Therapeutics plc | Oncology | $304.03M | +10.53% | |
| HBP.TO | Helix BioPharma Corp. | Oncology | $106.76M | +33.79% | |
| 4582.T | SymBio Pharmaceuticals Limited | Oncology | $31.19M | −4.55% | |
| Friday, Oct 30 · in 64 days · 4 companies | |||||
| AZN.L | AstraZeneca PLC | Oncology | $264.05B | −5.00% | |
| AZN | AstraZeneca PLC | Oncology | $263.12B | −3.60% | |
| 4568.T | Daiichi Sankyo Company, Limited | Oncology | $32.82B | −0.42% | |
| HOWL | Werewolf Therapeutics, Inc. | Oncology | $48.05M | +120.22% | |
| Monday, Nov 2 · in 67 days · 3 companies | |||||
| NUVB | Nuvation Bio Inc. | Oncology | $2.44B | +4.04% | |
| SNDX | Syndax Pharmaceuticals, Inc. | Oncology | $1.77B | +2.34% | |
| PYXS | Pyxis Oncology, Inc. | Oncology | $278.58M | +14.78% | |
| Tuesday, Nov 3 · in 68 days · 12 companies | |||||
| BNTX | BioNTech SE | Oncology | $28.28B | +21.75% | |
| COGT | Cogent Biosciences, Inc. | Oncology | $6.39B | −9.71% | |
| CRVS | Corvus Pharmaceuticals, Inc. | Oncology | $1.22B | +10.67% | |
| KURA | Kura Oncology, Inc. | Oncology | $1.16B | +40.28% | |
| RIGL | Rigel Pharmaceuticals, Inc. | Oncology | $864.97M | +20.73% | |
| NVCT | Nuvectis Pharma, Inc. | Oncology | $816.10M | +26.14% | |
| VSTM | Verastem, Inc. | Oncology | $641.19M | +18.62% | |
| DCTH | Delcath Systems, Inc. | Oncology | $569.06M | +41.99% | |
| 0LOV.L | Verastem, Inc. | Oncology | $470.33M | +3.62% | |
| 0J4V.L | Heron Therapeutics, Inc. | Oncology | $82.85M | −3.55% | |
| HRTX | Heron Therapeutics, Inc. | Oncology | $59.27M | −36.29% | |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | Oncology | $44.46M | −72.36% | |
| Wednesday, Nov 4 · in 69 days · 7 companies | |||||
| RVMD | Revolution Medicines, Inc. | Oncology | $46.18B | +17.18% | |
| TNGX | Tango Therapeutics, Inc. | Oncology | $4.29B | −4.43% | |
| XNCR | Xencor, Inc. Common Stock | Oncology | $2.11B | +42.41% | |
| VIR | Vir Biotechnology, Inc. | Oncology | $1.87B | +25.20% | |
| GERN | Geron Corporation | Oncology | $995.83M | +5.52% | |
| ARVN | Arvinas, Inc. | Oncology | $609.40M | +13.66% | |
| 0IV3.L | Geron Corporation | Oncology | $255.34M | −0.97% | |
| Thursday, Nov 5 · in 70 days · 32 companies | |||||
| ONC | BeOne Medicines AG | Oncology | $42.58B | +13.72% | |
| GMAB | Genmab A/S | Oncology | $21.42B | +16.38% | |
| GE9.DE | Genmab A/S | Oncology | $20.65B | +17.26% | |
| LNTH | Lantheus Holdings, Inc. | Oncology | $6.58B | −1.77% | |
| RLAY | Relay Therapeutics, Inc. | Oncology | $4.26B | +6.40% | |
| IMNM | Immunome, Inc. | Oncology | $3.34B | +23.82% | |
| ZLAB | Zai Lab Limited | Oncology | $2.92B | +39.80% | |
| URGN | UroGen Pharma Ltd. | Oncology | $2.25B | +12.38% | |
| ZYME | Zymeworks Inc. | Oncology | $2.10B | +29.61% | |
| IMCR | Immunocore Holdings plc | Oncology | $1.93B | +10.77% | |
| DMRA | Damora Therapeutics, Inc. | Oncology | $1.89B | +3.30% | |
| REPL | Replimune Group, Inc. | Oncology | $1.50B | +196.82% | |
| CGEM | Cullinan Therapeutics, Inc. | Oncology | $1.48B | +30.80% | |
| GLUE | Monte Rosa Therapeutics, Inc. | Oncology | $1.23B | −34.75% | |
| JANX | Janux Therapeutics, Inc. | Oncology | $1.15B | +25.93% | |
| CTMX | CytomX Therapeutics, Inc. | Oncology | $723.43M | +3.11% | |
| GUD.TO | Knight Therapeutics Inc. | Oncology | $690.78M | −0.81% | |
| CCCC | C4 Therapeutics, Inc. | Oncology | $521.63M | +19.44% | |
| PBYI | Puma Biotechnology, Inc. | Oncology | $472.84M | +14.93% | |
| CMPX | Compass Therapeutics, Inc. | Oncology | $437.61M | +19.12% | |
| FHTX | Foghorn Therapeutics Inc. | Oncology | $397.29M | +30.41% | |
| AGEN | Agenus Inc. | Oncology | $371.33M | +25.00% | |
| 0XOD.L | UroGen Pharma Ltd. | Oncology | $347.24M | −1.66% | |
| WHWK | Whitehawk Therapeutics, Inc. | Oncology | $275.92M | +31.52% | |
| CHRS | Coherus Oncology, Inc. | Oncology | $224.03M | +0.69% | |
| BDTX | Black Diamond Therapeutics, Inc. | Oncology | $130.42M | +28.98% | |
| PLRX | Pliant Therapeutics, Inc. | Oncology | $73.69M | +8.41% | |
| TPST | Tempest Therapeutics, Inc. | Oncology | $17.86M | +24.00% | |
| LSTA | Lisata Therapeutics, Inc. | Oncology | $15.68M | +50.00% | |
| 0GP7.L | Medivir AB (publ) | Oncology | $5.78M | +6.77% | |
| CRIS | Curis, Inc. | Oncology | $3.86M | −68.12% | |
| 0HS8.L | Lisata Therapeutics, Inc. | Oncology | — | +5.14% | |
| Friday, Nov 6 · in 71 days · 1 company | |||||
| ALXO | ALX Oncology Holdings Inc. | Oncology | $273.79M | −0.50% | |
| Monday, Nov 9 · in 74 days · 7 companies | |||||
| CGON | CG Oncology, Inc. | Oncology | $6.95B | +7.99% | |
| IDYA | IDEAYA Biosciences, Inc. | Oncology | $4.01B | +14.99% | |
| OLMA | Olema Pharmaceuticals, Inc. | Oncology | $949.35M | −6.63% | |
| TOI | Starling Oncology Inc | Oncology | $512.91M | +25.25% | |
| 0IL8.L | Kyntra Bio, Inc. | Oncology | $512.46M | +1.58% | |
| CATX | Perspective Therapeutics, Inc. | Oncology | $360.72M | +10.10% | |
| CGEN | Compugen Ltd. | Oncology | $271.86M | +25.66% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.